# Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

> **NCT06374264** · NA · ENROLLING_BY_INVITATION · sponsor: **MedRhythms, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Neuromyelitis Optica Spectrum Disorder

## Interventions

- **DEVICE:** MR-C-014

## Key facts

- **NCT ID:** NCT06374264
- **Lead sponsor:** MedRhythms, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-11-12
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06374264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06374264, "Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06374264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*